S. E. Harper

1.2k total citations
9 papers, 998 citations indexed

About

S. E. Harper is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, S. E. Harper has authored 9 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in S. E. Harper's work include Inflammatory mediators and NSAID effects (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). S. E. Harper is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Helicobacter pylori-related gastroenterology studies (3 papers). S. E. Harper collaborates with scholars based in United States, United Kingdom and Canada. S. E. Harper's co-authors include Hui Quan, Thomas Simon, James A. Bolognese, Loren Laine, R. N. Bath, Steven H. Stern, John F. Johanson, Howard Schwartz, Douglas J. Watson and Judith K. Evans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Hepatology.

In The Last Decade

S. E. Harper

9 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. E. Harper United States 9 804 332 243 126 109 9 998
Pritha Bhadra United States 7 628 0.8× 234 0.7× 95 0.4× 69 0.5× 63 0.6× 9 1.1k
G Castrucci Italy 8 414 0.5× 180 0.5× 347 1.4× 152 1.2× 58 0.5× 14 756
C. Alegre Spain 7 304 0.4× 123 0.4× 93 0.4× 43 0.3× 18 0.2× 12 523
Bianca M. Simonetti Italy 10 417 0.5× 83 0.3× 215 0.9× 216 1.7× 19 0.2× 15 869
L Wiśniewski United States 11 217 0.3× 313 0.9× 157 0.6× 77 0.6× 6 0.1× 20 842
P Needleman United States 11 457 0.6× 69 0.2× 161 0.7× 265 2.1× 9 0.1× 11 865
Gabriele Merciaro Italy 6 382 0.5× 93 0.3× 340 1.4× 79 0.6× 5 0.0× 6 561
Austin L. Leahy Ireland 13 260 0.3× 276 0.8× 213 0.9× 125 1.0× 4 0.0× 26 768
Susan Budinger United States 4 474 0.6× 217 0.7× 68 0.3× 49 0.4× 5 0.0× 4 926
Jean‐Louis David Belgium 19 149 0.2× 282 0.8× 481 2.0× 54 0.4× 5 0.0× 41 1.0k

Countries citing papers authored by S. E. Harper

Since Specialization
Citations

This map shows the geographic impact of S. E. Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. E. Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. E. Harper more than expected).

Fields of papers citing papers by S. E. Harper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. E. Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. E. Harper. The network helps show where S. E. Harper may publish in the future.

Co-authorship network of co-authors of S. E. Harper

This figure shows the co-authorship network connecting the top 25 collaborators of S. E. Harper. A scholar is included among the top collaborators of S. E. Harper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. E. Harper. S. E. Harper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hunt, Richard H., S. E. Harper, Douglas J. Watson, et al.. (2003). The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. The American Journal of Gastroenterology. 98(8). 1725–1733. 122 indexed citations
2.
Hunt, Richard H., S. E. Harper, Chang Yu, et al.. (2003). Complementary studies of the gastrointestinal safety of the cyclo‐oxygenase‐2‐selective inhibitor etoricoxib. Alimentary Pharmacology & Therapeutics. 17(2). 201–210. 87 indexed citations
3.
Hawkey, Christopher J., et al.. (2001). Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials. Alimentary Pharmacology & Therapeutics. 15(10). 1593–1601. 49 indexed citations
4.
Hawkey, C J, L. Jackson, S. E. Harper, et al.. (2001). The gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase‐2, in humans. Alimentary Pharmacology & Therapeutics. 15(1). 1–9. 41 indexed citations
5.
Watson, Douglas J., S. E. Harper, Peng-Liang Zhao, et al.. (2000). Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis. Archives of Internal Medicine. 160(19). 2998–2998. 138 indexed citations
6.
Lanza, Frank L., M F Rack, Thomas Simon, et al.. (1999). Specific inhibition of cyclooxygenase‐2 with MK‐0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen. Alimentary Pharmacology & Therapeutics. 13(6). 761–767. 147 indexed citations
7.
Laine, Loren, S. E. Harper, Thomas Simon, et al.. (1999). A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Gastroenterology. 117(4). 776–783. 357 indexed citations
8.
Harper, S. E. & Jules L. Dienstag. (1996). Can interferon alfa treatment prevent hepatocellular carcinoma in patients with chronic hepatitis C infection and compensated cirrhosis?. Hepatology. 23(4). 930–933. 12 indexed citations
9.
Harper, S. E., Yi Qiu, & P A Sharp. (1996). Sin3 corepressor function in Myc-induced transcription and transformation.. Proceedings of the National Academy of Sciences. 93(16). 8536–8540. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026